MYASTHENIA GRAVIS

This study tests whether a strong chemotherapy combination followed by a stem cell transplant can stop the immune system from attacking the brain, spinal cord, and nerves in people with autoimmune neurologic diseases that haven't improved with standard treatments. About 53 adults…

This study tests a drug called inebilizumab in 238 adults with myasthenia gravis, a disease that causes muscle weakness. The goal is to see if it improves daily activities like talking, swallowing, and moving. Participants receive either the drug or a placebo, and results are mea…

This study is testing a new robotic surgical system (da Vinci SP) for removing part or all of a lung (lobectomy) or the thymus gland (thymectomy) in people with lung cancer, benign lung disease, thymoma, or myasthenia gravis. The goal is to see if the system is safe and works wel…

This study tests an investigational drug called efgartigimod in adults with generalized myasthenia gravis (gMG) who do not have the typical acetylcholine receptor antibodies. The trial compares the drug to a placebo to see if it improves daily activities and muscle strength. Abou…

This study is a registry that will collect information from about 1,500 people with myasthenia gravis during their regular doctor visits. The goal is to better understand the disease and how well current treatments work. No new drugs or procedures are being tested.

This study is observing about 1,200 people with myasthenia gravis (MG) in China to understand how doctors currently treat the disease and how patients feel over time. Participants will have check-ups every 6 months until the end of 2027. The goal is to learn more about real-world…

This study aims to create a simple test to predict fall risk in people with neuromuscular disorders like muscular dystrophy, ALS, and myasthenia gravis. Researchers will measure how well participants perform tasks like standing up from a chair, walking, and balancing. The goal is…